| Cash Flow | 2025-10-31 | 2025-07-31 |
|---|---|---|
| Revenues | 445,115 | - |
| Adjusted cost of revenues | 148,581 | - |
| Adjusted sales and marketing expense | 78,753 | - |
| Adjusted research and development expense | 80,937 | - |
| Adjusted general and administrative expense | 42,145 | - |
| Interest income | 1,269 | - |
| Interest expense | 13,229 | - |
| Adjusted other (income) expense, net | 1,885 | - |
| Other segment items | 78,663 | - |
| Income tax provision (benefit) | 5,048 | - |
| Net income (loss) | 913 | -7,702 |
| Depreciation and amortization | 31,998 | 21,407 |
| Non-cash operating lease costs | 3,123 | 2,273 |
| Amortization of costs capitalized to obtain revenue contracts | 11,024 | 7,230 |
| Amortization of debt issuance costs | 215 | 144 |
| Stock-based compensation | 52,681 | 34,430 |
| Change in fair value of contingent consideration | 400 | 300 |
| Deferred income taxes | 2,579 | 4,003 |
| Provision for bad debt | 150 | 153 |
| Net foreign currency gains | 14,178 | 14,018 |
| Gains on investments | 1,652 | 1,652 |
| Loss on disposal of long-lived assets | -463 | -463 |
| Accounts receivable | -63,080 | -51,837 |
| Costs capitalized to obtain revenue contracts | 12,445 | 6,639 |
| Prepaid expenses and other assets | -1,482 | -1,629 |
| Accounts payable | -897 | 660 |
| Accrued expenses and other liabilities | -12,807 | -16,368 |
| Deferred revenue | -46,066 | -3,411 |
| Operating lease liabilities | 3,134 | 2,606 |
| Other long term liabilities | 198 | -77 |
| Net cash provided by operating activities | 77,127 | 72,056 |
| Acquisition of business, net of cash acquired | 50,263 | 50,263 |
| Acquisition of assets | 0 | 0 |
| Purchases of property and equipment | 7,040 | 6,866 |
| Sale of investment | 3,684 | 3,684 |
| Net cash used in investing activities | -53,619 | -53,445 |
| Repurchases of common stock | 100,080 | 60,598 |
| Proceeds from borrowings on revolving credit facility | 102,500 | 102,500 |
| Payments on revolving credit facility | 65,000 | 65,000 |
| Payments of debt issuance costs | 0 | 0 |
| Exercise of stock options | 1,566 | 1,294 |
| Stock issuance under the employee stock purchase plan | 2,444 | 2,444 |
| Principal payments on financing obligations | 1,245 | 824 |
| Net cash provided by (used in) financing activities | -59,815 | -20,184 |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | 2,922 | 3,529 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | -33,385 | 1,956 |
| Cash and cash equivalents at beginning of period | 121,267 | - |
| Cash and cash equivalents at end of period | 87,882 | - |
nCino, Inc. (NCNO)
nCino, Inc. (NCNO)